← FDA Drug Approvals (Drugs@FDA)
LIDOCAINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: DIFGEN PHARMS · Approved 2025-03-25
Drug application
- FDA Application #
ANDA217221- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- LIDOCAINE
- Generic name
- Lidocaine
- Active ingredients
- LIDOCAINE
- Dosage form
- PATCH
- Route
- TOPICAL
- Marketing status
- Prescription
- Sponsor
- DIFGEN PHARMS
- First approval
- 2025-03-25
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown